Shanet Susan Alex

Ph.D. Pharmacy

Shanet Susan Alex, a medical writer, based in Kerala, India, is a Doctor of Pharmacy graduate from Kerala University of Health Sciences. Her academic background is in clinical pharmacy and research, and she is passionate about medical writing. Shanet has published papers in the International Journal of Medical Science and Current Research (IJMSCR), the International Journal of Pharmacy (IJP), and the International Journal of Medical Science and Applied Research (IJMSAR). Apart from work, she enjoys listening to music and watching movies.

Articles from Shanet

How can researchers profile post-COVID syndromes among distinct SARS-CoV-2 variants?

In a new study, researchers profiled post-coronavirus disease (COVID) syndrome (PCS) throughout various SARS-CoV-2 variants.

2 Aug 2022

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

A new study monitored the safety of the second booster dose of SARS-CoV-2 messenger ribonucleic acid vaccination among those ≥50 Years.

2 Aug 2022

Long-term symptoms 23 months after SARS-CoV-2 infection

Scientists analyzed COVID-19 symptoms lasting 23 months after the infection.

2 Aug 2022

What are the hidden sources of SARS-CoV-2 evolution?

A recent article published in Transplant Infectious Disease examined case reports on SARS-CoV-2 evolution in immunosuppressed cohorts.

2 Aug 2022

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?

In a new study, scientists compared the effectiveness of the SARS-CoV-2 BNT162b2 and mRNA-1273 vaccines booster doses in England.

2 Aug 2022

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

A recent study published in the Journal of Food Biochemistry discovered that peimine from Fritillaria might be a possible SARS-CoV-2 variant infection inhibitor.

2 Aug 2022

Study finds asymptomatic SARS-CoV-2 infection induced comparable memory B cell responses to mild symptomatic infection in young adults

Researchers identified that among healthy young adults, the development of SARS-CoV-2 triggered memory B cell and antibody reactions were equivalent following mildly symptomatic or asymptomatic infections.

29 Jul 2022